BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8674108)

  • 1. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.
    Hakem R; de la Pompa JL; Sirard C; Mo R; Woo M; Hakem A; Wakeham A; Potter J; Reitmair A; Billia F; Firpo E; Hui CC; Roberts J; Rossant J; Mak TW
    Cell; 1996 Jun; 85(7):1009-23. PubMed ID: 8674108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brca2 is required for embryonic cellular proliferation in the mouse.
    Suzuki A; de la Pompa JL; Hakem R; Elia A; Yoshida R; Mo R; Nishina H; Chuang T; Wakeham A; Itie A; Koo W; Billia P; Ho A; Fukumoto M; Hui CC; Mak TW
    Genes Dev; 1997 May; 11(10):1242-52. PubMed ID: 9171369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
    Hakem R; de la Pompa JL; Elia A; Potter J; Mak TW
    Nat Genet; 1997 Jul; 16(3):298-302. PubMed ID: 9207798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.
    Ruland J; Sirard C; Elia A; MacPherson D; Wakeham A; Li L; de la Pompa JL; Cohen SN; Mak TW
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1859-64. PubMed ID: 11172041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
    Sourvinos G; Spandidos DA
    Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
    Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
    Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.
    Migliorini D; Lazzerini Denchi E; Danovi D; Jochemsen A; Capillo M; Gobbi A; Helin K; Pelicci PG; Marine JC
    Mol Cell Biol; 2002 Aug; 22(15):5527-38. PubMed ID: 12101245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.
    Ludwig T; Chapman DL; Papaioannou VE; Efstratiadis A
    Genes Dev; 1997 May; 11(10):1226-41. PubMed ID: 9171368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.
    Liu CY; Flesken-Nikitin A; Li S; Zeng Y; Lee WH
    Genes Dev; 1996 Jul; 10(14):1835-43. PubMed ID: 8698242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
    Hill DA; de la Serna IL; Veal TM; Imbalzano AN
    J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
    Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA
    Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality.
    Montes de Oca Luna R; Amelse LL; Chavez-Reyes A; Evans SC; Brugarolas J; Jacks T; Lozano G
    Nat Genet; 1997 Aug; 16(4):336-7. PubMed ID: 9241268
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.
    Smith PD; Crossland S; Parker G; Osin P; Brooks L; Waller J; Philp E; Crompton MR; Gusterson BA; Allday MJ; Crook T
    Oncogene; 1999 Apr; 18(15):2451-9. PubMed ID: 10229196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miz1 is required for early embryonic development during gastrulation.
    Adhikary S; Peukert K; Karsunky H; Beuger V; Lutz W; Elsässer HP; Möröy T; Eilers M
    Mol Cell Biol; 2003 Nov; 23(21):7648-57. PubMed ID: 14560010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 physically associates with p53 and stimulates its transcriptional activity.
    Zhang H; Somasundaram K; Peng Y; Tian H; Zhang H; Bi D; Weber BL; El-Deiry WS
    Oncogene; 1998 Apr; 16(13):1713-21. PubMed ID: 9582019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased apoptosis induction by 121F mutant p53.
    Saller E; Tom E; Brunori M; Otter M; Estreicher A; Mack DH; Iggo R
    EMBO J; 1999 Aug; 18(16):4424-37. PubMed ID: 10449408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
    Hohenstein P; Kielman MF; Breukel C; Bennett LM; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen GJ; Devilee P; Fodde R
    Oncogene; 2001 May; 20(20):2544-50. PubMed ID: 11420664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.